DIA: Driving Insights to Action

DIA/Tufts CSDD Research: AI Saving Time in Drug Development

DIA and the Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with 16 biopharmaceutical companies and CROs, conducted a study to map current u

DIA: Your Partner in Life Sciences Training and Development

This  podcast by the Drug Information Association (DIA) highlights the significant benefits of investing in professional development programs for employees in the life sc

DIA: Going Beyond the Traditional Definition of Drug Development

In this DIA 60th anniversary interview, former Board President Ling Su shares his thoughts on the two most important aspects of DIA’s future for the next generation of me

GPP Experts Explain Authorship Algorithm

Good Publication Practice (GPP) experts explain the authorship algorithm designed to weigh each author's contribution relative to other authors' contributions in a study,

"Dossier in the Cloud" Democratizing Global Access

Accumulus Synergy CEO Francisco Nogueira shares expectations for the outcomes of a post-approval changes pilot led by Roche which utilizes the Accumulus platform and foll

DIA: A Place Where You Can Make a Difference

Listen to former DIA Board President Minnie Baylor-Henry’s special message to DIA members as part of DIA’s 60th Anniversary celebration in 2024.

Autumn’s Leukemia Story: Regimens, Recovery, and Realizations

A few years ago, 8-year-old Autumn noticed a lump on the side of her neck as she was preparing for bed one night. That quiet night opened a new chapter not only in Autumn

Retiring TGA Head Maps Australia’s Post-Pandemic Future

In April 2023, Professor John Skerritt retired after 11 years of exemplary public service as deputy secretary of the Health Products Regulation Group and head of the Ther

Patient Engagement: Evolution of Who Knows What, Part 2

In part two of this podcast, “ePatients” Dave deBronkart and Stacy Hurt (Patient Advocacy Ambassador, Parexel) discuss new opportunities in the future of patient engageme

Patient Engagement: Evolution of Who Knows What, Part 1

DIA GAM 2023 Patient Engagement track chair Pujita Vaidya discusses the definition, history, and current state of patient engagement in clinical research and care with ca

Australian Clinical Trials Alliance Part 2 – Future Projections

“Healthcare systems obviously have as their primary role the delivery of healthcare,” says Steve Webb, Australian Clinical Trials Alliance board chair. “But we can see bi

ANVISA Explains Innovative Online Optimized Assessment Project

For regulators in Brazil, the pandemic’s aftermath includes a backlog of post-approval changes, delayed by emergency development of COVID-19 vaccines and therapies, relat

Australian Clinical Trials Alliance Part 1 – Current Perceptions

“The pandemic had a substantial impact on community understanding of clinical trials. Having said that, the sort of ambient level of community knowledge of clinical trial

Looking Back and Ahead: Translational Science Advances Impacting Patient Care

From microphysiological systems and digital pathology to next-generation-sequencing and diversity in foundational genomic data sets: In this iteration of our annual year

Rwanda Welcomes African Medicines Agency Home

While the African Medicines Agency (AMA) plans and plants its inaugural headquarters in Rwanda, the European Commission, the European Medicines Agency (EMA), several EU M

Will Technology Solve the Research “People Problem”?

Clinical trials struggle to enroll eligible patients, while interested patients have difficulty finding pertinent clinical trials. Can technology help solve this people p

Why Trans/Nonbinary Research Benefits All Communities

Actions to increase patient diversity in clinical research initially addressed racial and ethnic demographics but are expanding to address gender identity. “Further resea

Digital Revolutionizing Data-Driven Reimbursement

Digital technologies are rippling through clinical research and care, promising deeper links between healthcare research and delivery. In her interview with Global Forum

China Sets New Record for Local Drug Approvals in 2021

DIA Global Forum’s annual review of new drug approvals in China has shown growth in both the number and types of new drugs approved in China from 2019 through 2021: from

WHO Pilot Formalizes CSA Process to Assist Developers

The World Health Organization has initiated a pilot coordinated scientific advice (CSA) procedure whereby product developers may obtain WHO advice on the most appropriate